H.C. Wainwright analyst Edward White reiterated a Neutral rating on Bolt Biotherapeutics, Inc. (NASDAQ: BOLT).The analyst commented: "BDC-4182 is a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE